Navidea drops rheumatoid arthritis programme after failed Phase III trial
Exploratory analysis of Lymphoseek failed to predict which rheumatoid arthritis patients would respond to treatment with anti-TNFα therapy.
Clinical Trials Arena
Navigating clinical trial operations in the era of collaboration
Novartis eyes accelerated FDA approval for iptacopan across multiple indications
Novo Nordisk submitting once-weekly insulin to FDA following Phase III success
Schizophrenia trials continue to test drug candidates as Covid-19 pandemic continues
